Legend CEO Ying Huang resigns; Carvykti chief named interim leader
Legend Biotech, the developer of the blockbuster cancer therapy Carvykti, is in the market for a new CEO. Ying Huang stepped down Friday after serving as CEO since November 2020, Legend announced in a
Legend Biotech, the developer of the blockbuster cancer therapy Carvykti, is in the market for a new CEO.
Ying Huang stepped down Friday after serving as CEO since November 2020, Legend announced in a
Source: Endpoints News